Dental Crowns & Bridges Market by Product Type (Bridges, Crowns), Material (All Ceramic, Metal, Porcelain Fused To Metal), Technology, Distribution Channel, End User - Global Forecast 2025-2032
Description
The Dental Crowns & Bridges Market was valued at USD 4.28 billion in 2024 and is projected to grow to USD 4.54 billion in 2025, with a CAGR of 6.94%, reaching USD 7.32 billion by 2032.
A disciplined orientation to crowns and bridges that outlines clinical priorities technological shifts supply chain dynamics and the evolving decision framework for stakeholders
The restorative dentistry landscape has entered a period of accelerated transformation driven by converging clinical priorities, digital innovation, and supply chain realignment. Crowns and bridges remain foundational in prosthodontics, addressing tooth loss and structural restoration needs across patient demographics. Clinicians and providers are navigating a more complex decision matrix where material science, aesthetic outcomes, procedural efficiency, and long-term durability must be balanced for each patient. As a result, product development and clinical protocols are increasingly informed by evidence from laboratory research, clinical trials, and real-world practice data.
Simultaneously, dental laboratories, manufacturers, and distribution partners are adapting to new workflow paradigms that emphasize digital impressions, CAD/CAM fabrication, and centralized material sourcing. These advances reduce turnaround times and enhance reproducibility while introducing distinct operational and regulatory considerations. In this context, stakeholders must appraise not only the clinical merits of restorative options but also the downstream effects on procurement, inventory strategies, and training requirements. The introduction of advanced ceramics and high-translucency zirconia variants has further expanded clinicians’ options, prompting a reassessment of traditional metal-based solutions in many settings.
An incisive examination of rapid digitalization material innovation distribution transformation and regulatory pressures that are reshaping restorative dentistry practice models
The last several years have seen transformative shifts that are redefining how crowns and bridges are designed, manufactured, and delivered. Digital dentistry has moved from early adoption into mainstream clinical practice, enabling chairside and centralized CAD/CAM workflows that shorten procedural timelines and raise consistency of fit. This digital transition has important downstream effects: it changes laboratory service models, encourages vertical integration by manufacturers, and creates new points of competitive differentiation based on software ecosystems, scanner compatibility, and material partnerships.
Material innovation has also been a central axis of change. Advances in high-strength ceramics and multi-layer zirconia formulations have narrowed the aesthetic and functional gaps that once favored metal-based restorations for specific indications. Concurrently, clinicians are applying evidence-based selection criteria to optimize patient outcomes, placing a premium on biocompatibility, wear characteristics, and long-term stability. Distribution channels are diversifying as procurement moves online and manufacturers explore direct-to-clinic relationships. Regulatory scrutiny and heightened quality assurance expectations are influencing manufacturing practices, while workforce training and adoption curves remain critical determinants of the pace of transformation. Taken together, these shifts create both opportunity and complexity for manufacturers, laboratories, clinicians, and payers.
A clear analysis of how recent tariff changes are compelling procurement realignment supply base diversification and manufacturing localization across restorative dentistry value chains
Policy shifts in tariff regimes can have material implications across supply chains for restorative dental products, particularly when raw materials, semi-finished components, or finished prostheses traverse international routes. The cumulative impact of recent tariff adjustments has placed upward pressure on landed costs for some imported materials and components, prompting firms to reassess procurement strategies and total cost of ownership for restorative solutions. In response, manufacturers and dental laboratories have evaluated alternative supply bases, localized certain production stages, and increased inventory buffers to mitigate exposure to cross-border cost volatility.
These adaptive measures have broader strategic consequences. Nearshoring and regional sourcing can improve responsiveness and reduce lead times, but they often require capital investment, requalification of suppliers, and supply chain reconfiguration. Clinical providers and purchasing organizations are negotiating differently, prioritizing transparency on origin and unit cost drivers. Tariff-related cost changes also accelerate interest in digital manufacturing that can consolidate production and reduce dependency on imported conventional components. While tariffs are only one variable among many influencing procurement, their effect on pricing structures, contract negotiations, and supplier selection has become a persistent consideration for stakeholders planning multi-year investments in restorative technologies.
A comprehensive exploration of segmentation nuances covering product types materials end users distribution channels and technology choices that drive procurement and clinical outcomes
Granular segmentation reveals the nuanced competitive and clinical dynamics that define crowns and bridges supply and demand. When product type is considered, restorative decision-making differentiates between bridges and crowns, with each category imposing distinct biomechanical and aesthetic requirements that influence material choice and fabrication processes. Material segmentation is especially instructive: all-ceramic restorations, including alumina and lithium disilicate subtypes, are often selected for their aesthetic integration and favorable wear patterns, whereas metal and porcelain-fused-to-metal options retain relevance for applications where strength and margin design are paramount. Zirconia variants, spanning dense solid formulations to newer translucent grades, present a continuum of trade-offs between strength and optical properties that clinicians evaluate against case-specific requirements.
End-user segmentation highlights divergent procurement and utilization patterns across academic and research institutes, dental clinics, and hospitals. Academic centers tend to prioritize access to novel materials and research-driven workflows, while private clinics emphasize efficient, aesthetic solutions that fit procedural economics, and hospitals integrate restorative services within broader surgical and inpatient workflows. Distribution channel segmentation shows a shift in how products reach end users: direct sales models, whether through company representatives or corporate contracts, support relationship-driven procurement for high-touch clients, while online channels-both manufacturer websites and marketplaces-facilitate scalable ordering and rapid replenishment. Retail remains important for some consumables and patient-facing products. Finally, technology segmentation between CAD/CAM and conventional processes outlines the divergence in capital investment, staff training, and workflow optimization required to implement each approach successfully.
A strategic regional assessment of demand drivers regulatory contrasts manufacturing hubs and adoption patterns across the Americas Europe Middle East Africa and Asia-Pacific
Regional dynamics vary significantly and shape strategic priorities for manufacturers, laboratories, and clinical providers. In the Americas, demand drivers emphasize procedural efficiency, integration of digital workflows, and a strong private practice network that favors predictable supply channels and rapid support for digital equipment. This region also demonstrates advanced adoption of aesthetic ceramics and high-translucency zirconia variants, supported by a mature laboratory ecosystem that balances in-house CAD/CAM capabilities with outsourced fabrication.
Europe, the Middle East and Africa present a heterogeneous picture where regulatory frameworks, reimbursement models, and varying clinical practices influence product selection and distribution. Western European markets typically exhibit high standards for material biocompatibility and process validation, while emerging markets within the region display growing interest in digital tools that can expand access to restorative care. In the Asia-Pacific region, rapid clinical infrastructure development, sizable dental laboratory networks, and an expanding middle-class patient base are accelerating uptake of both conventional and digital restorative solutions. This region also serves as a major manufacturing hub for materials and components, which in turn interacts with global supply considerations and tariff-sensitive sourcing strategies.
An authoritative review of competitive strategies strategic collaborations innovation focus areas and laboratory dynamics that determine success in restorative dentistry markets
Competitive dynamics in crowns and bridges are shaped by a mix of legacy dental materials manufacturers, technology-focused entrants, and specialized laboratory networks. Established firms have leveraged brand recognition, regulatory experience, and broad product portfolios to maintain strong channels into clinical and laboratory markets. Meanwhile, newer entrants-often focused on digital platforms, software-enabled workflows, or advanced ceramic formulations-are challenging incumbent models by emphasizing integration, user experience, and materials that meet evolving aesthetic expectations.
Collaborations between material specialists and digital equipment providers are increasingly common as stakeholders seek to deliver end-to-end solutions that reduce friction for clinicians. Strategic partnerships, licensing arrangements, and selective acquisitions are tools companies use to access complementary capabilities, enter new geographies, or accelerate innovation cycles. Laboratory consolidations and vertical integration by larger OEMs are also altering competitive structures, as control over fabrication and material supply can create tighter feedback loops for product improvement. For decision-makers, understanding where companies are investing-whether in R&D for novel ceramics, expansion of CAD/CAM service footprints, or digital platform interoperability-provides a practical lens on where incremental value will be created.
A pragmatic set of strategic and operational recommendations to accelerate innovation optimize supply resilience and expand commercial reach while reducing adoption friction for clinicians
Industry leaders should pursue a balanced strategy that aligns product innovation with operational resilience and customer-centric services. Prioritize investments in material research that address both aesthetic demands and mechanical performance, while ensuring rigorous validation and ease of use for clinical workflows. Simultaneously, develop interoperable digital solutions that integrate with popular intraoral scanners and laboratory software to reduce adoption friction and strengthen customer retention. These technical strategies should be complemented by supply chain initiatives that diversify sourcing, assess nearshoring opportunities where feasible, and build contingency plans for tariff or logistics disruptions.
Commercial approaches must adapt too: expand direct engagement with high-value clinical accounts through dedicated field teams and contract solutions, while scaling online channels to serve broader clinic networks. Offer value-added services such as training, digital onboarding, and outcome support to differentiate offerings beyond price alone. Finally, align regulatory and quality assurance investments with regional market entry plans to reduce time-to-adoption and to facilitate clinician confidence in new materials and workflows. By combining technical excellence with pragmatic commercial and supply chain strategies, leaders can sustain growth while reducing exposure to external shocks.
A rigorous triangulated research methodology combining primary stakeholder engagement clinical literature regulatory review and scenario analysis to deliver verifiable actionable insights
The research approach integrates a triangulated methodology combining primary stakeholder engagement with comprehensive secondary evidence to ensure balanced, verifiable insights. Primary inputs comprised structured interviews with clinicians, laboratory managers, procurement officers, and manufacturing executives, supplemented by technical discussions with material scientists and device engineers. These qualitative inputs were used to contextualize product selection drivers, workflow barriers, and distribution preferences across end users. Secondary evidence was derived from peer-reviewed clinical literature, regulatory filings, product technical dossiers, and publicly available company disclosures to validate material performance attributes and to confirm technology adoption narratives.
Analytical steps included mapping segmentation frameworks to clinical use cases, synthesizing supply chain flowcharts, and stress-testing strategic scenarios related to tariffs and sourcing shifts. Data validation incorporated cross-verification of primary claims with laboratory case studies and product specifications, with attention to ensuring reproducibility of findings. Limitations include variability in reporting practices across regions and the evolving nature of material science developments; these were addressed by emphasizing triangulation and by noting where assumptions were required. The methodology was designed to prioritize transparency, traceability, and actionability for stakeholders seeking to translate insights into operational decisions.
A concise concluding synthesis emphasizing the imperative to integrate material innovation digital workflows and resilient sourcing for sustained clinical and commercial success
In conclusion, crowns and bridges remain a core pillar of restorative dentistry, but the ecosystem that supports them is in active transition. Digital workflows, material evolution, and supply chain realignment are converging to create both opportunities for differentiation and new operational complexities. Clinicians and providers will need to balance aesthetic and functional expectations with procedural efficiency and cost considerations, while manufacturers and laboratories must adapt their product platforms and service models to support these evolving needs.
Successful organizations will be those that integrate material innovation with seamless digital workflows, cultivate resilient sourcing strategies, and invest in customer enablement to shorten adoption cycles. Regulatory diligence and clinical validation will continue to be pivotal for credibility and market acceptance. Stakeholders that take a disciplined, evidence-based approach to technology adoption, segmentation-focused product development, and regionally nuanced go-to-market strategies will be best positioned to deliver superior patient outcomes and sustainable commercial performance.
Note: PDF & Excel + Online Access - 1 Year
A disciplined orientation to crowns and bridges that outlines clinical priorities technological shifts supply chain dynamics and the evolving decision framework for stakeholders
The restorative dentistry landscape has entered a period of accelerated transformation driven by converging clinical priorities, digital innovation, and supply chain realignment. Crowns and bridges remain foundational in prosthodontics, addressing tooth loss and structural restoration needs across patient demographics. Clinicians and providers are navigating a more complex decision matrix where material science, aesthetic outcomes, procedural efficiency, and long-term durability must be balanced for each patient. As a result, product development and clinical protocols are increasingly informed by evidence from laboratory research, clinical trials, and real-world practice data.
Simultaneously, dental laboratories, manufacturers, and distribution partners are adapting to new workflow paradigms that emphasize digital impressions, CAD/CAM fabrication, and centralized material sourcing. These advances reduce turnaround times and enhance reproducibility while introducing distinct operational and regulatory considerations. In this context, stakeholders must appraise not only the clinical merits of restorative options but also the downstream effects on procurement, inventory strategies, and training requirements. The introduction of advanced ceramics and high-translucency zirconia variants has further expanded clinicians’ options, prompting a reassessment of traditional metal-based solutions in many settings.
An incisive examination of rapid digitalization material innovation distribution transformation and regulatory pressures that are reshaping restorative dentistry practice models
The last several years have seen transformative shifts that are redefining how crowns and bridges are designed, manufactured, and delivered. Digital dentistry has moved from early adoption into mainstream clinical practice, enabling chairside and centralized CAD/CAM workflows that shorten procedural timelines and raise consistency of fit. This digital transition has important downstream effects: it changes laboratory service models, encourages vertical integration by manufacturers, and creates new points of competitive differentiation based on software ecosystems, scanner compatibility, and material partnerships.
Material innovation has also been a central axis of change. Advances in high-strength ceramics and multi-layer zirconia formulations have narrowed the aesthetic and functional gaps that once favored metal-based restorations for specific indications. Concurrently, clinicians are applying evidence-based selection criteria to optimize patient outcomes, placing a premium on biocompatibility, wear characteristics, and long-term stability. Distribution channels are diversifying as procurement moves online and manufacturers explore direct-to-clinic relationships. Regulatory scrutiny and heightened quality assurance expectations are influencing manufacturing practices, while workforce training and adoption curves remain critical determinants of the pace of transformation. Taken together, these shifts create both opportunity and complexity for manufacturers, laboratories, clinicians, and payers.
A clear analysis of how recent tariff changes are compelling procurement realignment supply base diversification and manufacturing localization across restorative dentistry value chains
Policy shifts in tariff regimes can have material implications across supply chains for restorative dental products, particularly when raw materials, semi-finished components, or finished prostheses traverse international routes. The cumulative impact of recent tariff adjustments has placed upward pressure on landed costs for some imported materials and components, prompting firms to reassess procurement strategies and total cost of ownership for restorative solutions. In response, manufacturers and dental laboratories have evaluated alternative supply bases, localized certain production stages, and increased inventory buffers to mitigate exposure to cross-border cost volatility.
These adaptive measures have broader strategic consequences. Nearshoring and regional sourcing can improve responsiveness and reduce lead times, but they often require capital investment, requalification of suppliers, and supply chain reconfiguration. Clinical providers and purchasing organizations are negotiating differently, prioritizing transparency on origin and unit cost drivers. Tariff-related cost changes also accelerate interest in digital manufacturing that can consolidate production and reduce dependency on imported conventional components. While tariffs are only one variable among many influencing procurement, their effect on pricing structures, contract negotiations, and supplier selection has become a persistent consideration for stakeholders planning multi-year investments in restorative technologies.
A comprehensive exploration of segmentation nuances covering product types materials end users distribution channels and technology choices that drive procurement and clinical outcomes
Granular segmentation reveals the nuanced competitive and clinical dynamics that define crowns and bridges supply and demand. When product type is considered, restorative decision-making differentiates between bridges and crowns, with each category imposing distinct biomechanical and aesthetic requirements that influence material choice and fabrication processes. Material segmentation is especially instructive: all-ceramic restorations, including alumina and lithium disilicate subtypes, are often selected for their aesthetic integration and favorable wear patterns, whereas metal and porcelain-fused-to-metal options retain relevance for applications where strength and margin design are paramount. Zirconia variants, spanning dense solid formulations to newer translucent grades, present a continuum of trade-offs between strength and optical properties that clinicians evaluate against case-specific requirements.
End-user segmentation highlights divergent procurement and utilization patterns across academic and research institutes, dental clinics, and hospitals. Academic centers tend to prioritize access to novel materials and research-driven workflows, while private clinics emphasize efficient, aesthetic solutions that fit procedural economics, and hospitals integrate restorative services within broader surgical and inpatient workflows. Distribution channel segmentation shows a shift in how products reach end users: direct sales models, whether through company representatives or corporate contracts, support relationship-driven procurement for high-touch clients, while online channels-both manufacturer websites and marketplaces-facilitate scalable ordering and rapid replenishment. Retail remains important for some consumables and patient-facing products. Finally, technology segmentation between CAD/CAM and conventional processes outlines the divergence in capital investment, staff training, and workflow optimization required to implement each approach successfully.
A strategic regional assessment of demand drivers regulatory contrasts manufacturing hubs and adoption patterns across the Americas Europe Middle East Africa and Asia-Pacific
Regional dynamics vary significantly and shape strategic priorities for manufacturers, laboratories, and clinical providers. In the Americas, demand drivers emphasize procedural efficiency, integration of digital workflows, and a strong private practice network that favors predictable supply channels and rapid support for digital equipment. This region also demonstrates advanced adoption of aesthetic ceramics and high-translucency zirconia variants, supported by a mature laboratory ecosystem that balances in-house CAD/CAM capabilities with outsourced fabrication.
Europe, the Middle East and Africa present a heterogeneous picture where regulatory frameworks, reimbursement models, and varying clinical practices influence product selection and distribution. Western European markets typically exhibit high standards for material biocompatibility and process validation, while emerging markets within the region display growing interest in digital tools that can expand access to restorative care. In the Asia-Pacific region, rapid clinical infrastructure development, sizable dental laboratory networks, and an expanding middle-class patient base are accelerating uptake of both conventional and digital restorative solutions. This region also serves as a major manufacturing hub for materials and components, which in turn interacts with global supply considerations and tariff-sensitive sourcing strategies.
An authoritative review of competitive strategies strategic collaborations innovation focus areas and laboratory dynamics that determine success in restorative dentistry markets
Competitive dynamics in crowns and bridges are shaped by a mix of legacy dental materials manufacturers, technology-focused entrants, and specialized laboratory networks. Established firms have leveraged brand recognition, regulatory experience, and broad product portfolios to maintain strong channels into clinical and laboratory markets. Meanwhile, newer entrants-often focused on digital platforms, software-enabled workflows, or advanced ceramic formulations-are challenging incumbent models by emphasizing integration, user experience, and materials that meet evolving aesthetic expectations.
Collaborations between material specialists and digital equipment providers are increasingly common as stakeholders seek to deliver end-to-end solutions that reduce friction for clinicians. Strategic partnerships, licensing arrangements, and selective acquisitions are tools companies use to access complementary capabilities, enter new geographies, or accelerate innovation cycles. Laboratory consolidations and vertical integration by larger OEMs are also altering competitive structures, as control over fabrication and material supply can create tighter feedback loops for product improvement. For decision-makers, understanding where companies are investing-whether in R&D for novel ceramics, expansion of CAD/CAM service footprints, or digital platform interoperability-provides a practical lens on where incremental value will be created.
A pragmatic set of strategic and operational recommendations to accelerate innovation optimize supply resilience and expand commercial reach while reducing adoption friction for clinicians
Industry leaders should pursue a balanced strategy that aligns product innovation with operational resilience and customer-centric services. Prioritize investments in material research that address both aesthetic demands and mechanical performance, while ensuring rigorous validation and ease of use for clinical workflows. Simultaneously, develop interoperable digital solutions that integrate with popular intraoral scanners and laboratory software to reduce adoption friction and strengthen customer retention. These technical strategies should be complemented by supply chain initiatives that diversify sourcing, assess nearshoring opportunities where feasible, and build contingency plans for tariff or logistics disruptions.
Commercial approaches must adapt too: expand direct engagement with high-value clinical accounts through dedicated field teams and contract solutions, while scaling online channels to serve broader clinic networks. Offer value-added services such as training, digital onboarding, and outcome support to differentiate offerings beyond price alone. Finally, align regulatory and quality assurance investments with regional market entry plans to reduce time-to-adoption and to facilitate clinician confidence in new materials and workflows. By combining technical excellence with pragmatic commercial and supply chain strategies, leaders can sustain growth while reducing exposure to external shocks.
A rigorous triangulated research methodology combining primary stakeholder engagement clinical literature regulatory review and scenario analysis to deliver verifiable actionable insights
The research approach integrates a triangulated methodology combining primary stakeholder engagement with comprehensive secondary evidence to ensure balanced, verifiable insights. Primary inputs comprised structured interviews with clinicians, laboratory managers, procurement officers, and manufacturing executives, supplemented by technical discussions with material scientists and device engineers. These qualitative inputs were used to contextualize product selection drivers, workflow barriers, and distribution preferences across end users. Secondary evidence was derived from peer-reviewed clinical literature, regulatory filings, product technical dossiers, and publicly available company disclosures to validate material performance attributes and to confirm technology adoption narratives.
Analytical steps included mapping segmentation frameworks to clinical use cases, synthesizing supply chain flowcharts, and stress-testing strategic scenarios related to tariffs and sourcing shifts. Data validation incorporated cross-verification of primary claims with laboratory case studies and product specifications, with attention to ensuring reproducibility of findings. Limitations include variability in reporting practices across regions and the evolving nature of material science developments; these were addressed by emphasizing triangulation and by noting where assumptions were required. The methodology was designed to prioritize transparency, traceability, and actionability for stakeholders seeking to translate insights into operational decisions.
A concise concluding synthesis emphasizing the imperative to integrate material innovation digital workflows and resilient sourcing for sustained clinical and commercial success
In conclusion, crowns and bridges remain a core pillar of restorative dentistry, but the ecosystem that supports them is in active transition. Digital workflows, material evolution, and supply chain realignment are converging to create both opportunities for differentiation and new operational complexities. Clinicians and providers will need to balance aesthetic and functional expectations with procedural efficiency and cost considerations, while manufacturers and laboratories must adapt their product platforms and service models to support these evolving needs.
Successful organizations will be those that integrate material innovation with seamless digital workflows, cultivate resilient sourcing strategies, and invest in customer enablement to shorten adoption cycles. Regulatory diligence and clinical validation will continue to be pivotal for credibility and market acceptance. Stakeholders that take a disciplined, evidence-based approach to technology adoption, segmentation-focused product development, and regionally nuanced go-to-market strategies will be best positioned to deliver superior patient outcomes and sustainable commercial performance.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
181 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Rising adoption of chairside CAD/CAM systems improving turnaround for same-day ceramic crowns
- 5.2. Growing preference for biocompatible zirconia-based restorations over traditional metal ceramics
- 5.3. Increased utilization of 3D printing technologies for customized dental bridge frameworks
- 5.4. Expansion of digital intraoral scanning reducing need for conventional impressions in prosthodontics
- 5.5. Surge in tele-dentistry consultations influencing remote design and laboratory workflows for crowns and bridges
- 5.6. Environmental sustainability driving development of recyclable crown and bridge materials and processes
- 5.7. Integration of artificial intelligence in prosthetic design to optimize fit occlusion and patient comfort
- 5.8. Demand for esthetic anterior restorations boosting lithium disilicate glass ceramic innovations in dentistry
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Dental Crowns & Bridges Market, by Product Type
- 8.1. Bridges
- 8.2. Crowns
- 9. Dental Crowns & Bridges Market, by Material
- 9.1. All Ceramic
- 9.1.1. Alumina
- 9.1.2. Lithium Disilicate
- 9.2. Metal
- 9.3. Porcelain Fused To Metal
- 9.4. Zirconia
- 9.4.1. Solid Zirconia
- 9.4.2. Translucent Zirconia
- 10. Dental Crowns & Bridges Market, by Technology
- 10.1. Cad/Cam
- 10.2. Conventional
- 11. Dental Crowns & Bridges Market, by Distribution Channel
- 11.1. Direct Sales
- 11.1.1. Company Representatives
- 11.1.2. Corporate Contracts
- 11.2. Online
- 11.2.1. Manufacturer Websites
- 11.2.2. Marketplaces
- 11.3. Retail
- 12. Dental Crowns & Bridges Market, by End User
- 12.1. Academic & Research Institutes
- 12.2. Dental Clinics
- 12.3. Hospitals
- 13. Dental Crowns & Bridges Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Dental Crowns & Bridges Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Dental Crowns & Bridges Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. 3M Company
- 16.3.2. AVINENT IMPLANT SYSTEM, S.L.U.
- 16.3.3. Bicon Dental Implants
- 16.3.4. BioHorizons, Inc.
- 16.3.5. CAMLOG Biotechnologies GmbH
- 16.3.6. Cheng Crowns
- 16.3.7. Cortex Dental Implants Industries Ltd.
- 16.3.8. Danaher Corporation
- 16.3.9. Dentium USA
- 16.3.10. Dentsply Sirona
- 16.3.11. DIO IMPLANT CO.,LTD.
- 16.3.12. Institut Straumann AG
- 16.3.13. Ivoclar Vivadent AG
- 16.3.14. James R. Glidewell, Dental Ceramics, Inc.
- 16.3.15. MegaGen Implant Co., Ltd
- 16.3.16. Merz Dental GmbH
- 16.3.17. Neoss Limited
- 16.3.18. OSSTEM IMPLANT CO., LTD.
- 16.3.19. Planmeca Oy
- 16.3.20. Sweden & Martina S.p.A.
- 16.3.21. TBR Group
- 16.3.22. Thommen Medical AG
- 16.3.23. Zimmer Biomet
- 16.3.24. ZimVie Inc.
- 16.3.25. Zirkonzahn srl
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
